Metfora is developing a blood test that can quickly recognize chronic lung, and heart disorders, and cancers in their early stages.
Metfora has raised $30K in total funding. The most recent round was Grant. The last funding was announced in April 2024.
Metfora's investors include National Science Foundation, AZBio.
Metfora is headquartered in Tucson, United States.
Metfora is developing a blood test that can quickly recognize chronic lung, and heart disorders, and cancers in their early stages.
Metfora is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Metfora — Funding & Investors." VCBacked, April 3, 2024, https://www.vcbacked.co/company/metfora. Accessed September 30, 2026.
VCBacked. (2024). Metfora — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/metfora
{{cite web |title=Metfora — Funding & Investors |url=https://www.vcbacked.co/company/metfora |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated